Financial Ratios

DR. REDDY'S LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE5885.00-74.1 (-1.24 %)
PREV CLOSE ( ) 5959.10
OPEN PRICE ( ) 5960.55
BID PRICE (QTY) 5883.10 (1)
OFFER PRICE (QTY) 5885.00 (28)
VOLUME 11565
TODAY'S LOW / HIGH ( )5881.15 5970.00
52 WK LOW / HIGH ( )4383.4 6505.5
NSE5887.00-70.15 (-1.18 %)
PREV CLOSE( ) 5957.15
OPEN PRICE ( ) 6000.00
BID PRICE (QTY) 5885.20 (1)
OFFER PRICE (QTY) 5887.00 (30)
VOLUME 151117
TODAY'S LOW / HIGH( ) 5885.00 6000.00
52 WK LOW / HIGH ( )4384.05 6505.9
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)156.8397.55131.39176.7676.95
   CEPS(Rs)212.24146.48181.57224.24123.97
   DPS(Rs)40.0030.0025.0025.0020.00
   Book NAV/Share(Rs)1220.201093.321013.05907.83759.31
   Tax Rate(%)32.4227.0128.46-5.8324.90
Margin Ratios
   Core EBITDA Margin(%)24.8518.0123.5024.2221.31
   EBIT Margin(%)22.8915.7023.2423.8316.54
   Pre Tax Margin(%)22.7915.4422.8923.4216.01
   PAT Margin (%)15.4011.2716.3824.7912.02
   Cash Profit Margin (%)20.8516.9222.6331.4519.37
Performance Ratios
   ROA(%)10.487.0810.8716.737.68
   ROE(%)13.579.2613.6921.2210.50
   ROCE(%)18.9111.6817.8118.5812.49
   Asset Turnover(x)0.680.630.660.680.64
   Sales/Fixed Asset(x)1.191.121.181.191.12
   Working Capital/Sales(x)1.841.932.092.001.82
Efficiency Ratios
   Fixed Capital/Sales(x)0.840.890.850.840.89
   Receivable days99.35114.34119.20128.69136.06
   Inventory Days68.7678.1468.4964.7766.51
   Payable days115.51104.98102.82100.38119.58
Valuation Parameters
   PER(x)29.4744.1434.3717.6336.05
   PCE(x)21.7729.3924.8713.9022.38
   Price/Book(x)3.793.944.463.433.65
   Yield(%)0.870.700.550.800.72
   EV/Net Sales(x)4.504.995.604.494.42
   EV/Core EBITDA(x)15.9023.3518.9714.7318.52
   EV/EBIT(x)19.6831.7524.0818.8526.74
   EV/CE(x)3.012.933.502.822.89
   M Cap / Sales4.544.975.634.374.33
Growth Ratio
   Net Sales Growth(%)17.757.9112.6511.5313.53
   Core EBITDA Growth(%)56.24-21.889.0042.3465.47
   EBIT Growth(%)71.67-27.119.8960.66131.31
   PAT Growth(%)60.97-25.76-25.57129.99125.31
   EPS Growth(%)60.77-25.76-25.66129.72125.31
Financial Stability Ratios
   Total Debt/Equity(x)0.000.120.070.100.08
   Current Ratio(x)3.082.232.402.422.90
   Quick Ratio(x)2.401.681.781.892.25
   Interest Cover(x)229.7659.5266.4459.0730.94
   Total Debt/Mcap(x)0.000.030.020.030.02

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.